Bextra
| Prescription Drug Manufacturer Pfizer Withdraws Bextra from Market April 7, 2005 Citing concerns regarding the risk of heart attacks, strokes, "life threatening" skin reactions, and other cardiovascular events the FDA requested that drugmaker Pfizer withdraw Bextra from U.S. and European pharmaceutical markets. The FDA stated that Bextra's dangerous side effects outweigh the benefits of the medication. "For now, patients should stop taking Bextra and contact their physicians about appropriate treatment options," Pfizer said in a statement Thursday. |
More About Bextra:
Bextra has been linked to Stevens Johnson Syndrome and other skin hypersensitivity disorders and side effects. Bextra is used to treat osteoarthritis and adult rheumatoid arthritis, pain associated with menstrual cramping, and for the treatment of primary dysmenorrhera.
Stevens Johnson Syndrome is an extreme allergic reaction to chemicals. Common causes are the drugs including Arava (leflunomide), painkillers, and antibiotics. Bextra has now been linked to this potentially life threatening syndrome.
Symptoms of Stevens Johnson Syndrome are skin rash, swelling or blistering of skin, difficulty breathing, fever, cough, malaise, swelling of face, swelling and lesions of gums, tongue or lips, excessive tearing or stickiness of eyes and sores in the genital tract causing painful urination.
Patients who have severe allergies to antibiotics should not use Bextra. If you develop any of the above symptoms consult your doctor immediately.
Bextra is a COX-2 inhibitor, marketed by Pharmacia Corporation and Pfizer, Inc. in the United States. Celebrex was the first of Pharmacia's COX-2 inhibitors.
Individuals that have experienced adverse effects from taking Bextra should contact us to learn your legal rights and options.
We bring this important information to your attention to better educate you about the risks and dangers of prescription and pharmaceutical drugs.
PRESCRIPTION DRUG QUESTIONS & ANSWERS
- Arava FAQs
- Meridia FAQs
- Prempro FAQs
- Vioxx FAQs
At Munley, Munley & Cartwright, our goal is to provide exceptional legal services to our clients. We strive to achieve the highest standard of excellence for the protection of individual rights through team work and the use of our considerable resources and experience. For a free consultation regarding your legal concerns, contact us today for a free consultation or call us toll free at 1-800-318-LAW1.
